Michael Sweeney

4.4k total citations
42 papers, 1.8k citations indexed

About

Michael Sweeney is a scholar working on Neurology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, Michael Sweeney has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 12 papers in Clinical Psychology and 12 papers in Psychiatry and Mental health. Recurrent topics in Michael Sweeney's work include Pain Mechanisms and Treatments (8 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Child and Adolescent Psychosocial and Emotional Development (6 papers). Michael Sweeney is often cited by papers focused on Pain Mechanisms and Treatments (8 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Child and Adolescent Psychosocial and Emotional Development (6 papers). Michael Sweeney collaborates with scholars based in United States, United Kingdom and Canada. Michael Sweeney's co-authors include C Conti, Roger Kirby, Georg Bartsch, A Jardin, Claus G. Roehrborn, Eric Grossman, Peter Boyle, Michael Crager, Michael J. Koren and A. Shpilsky and has published in prestigious journals such as Journal of the American College of Cardiology, Neurology and Pain.

In The Last Decade

Michael Sweeney

42 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Sweeney	587	543	415	349	263	42	1.8k
Loukia M. Spineli	1.8k 3.1×	398 0.7×	147 0.4×	97 0.3×	231 0.9×	60	3.0k
Martín Dossenbach	1.6k 2.7×	480 0.9×	161 0.4×	56 0.2×	148 0.6×	78	2.3k
Sean Martin	186 0.3×	118 0.2×	609 1.5×	278 0.8×	311 1.2×	73	2.2k
Ulla Rajala	125 0.2×	87 0.2×	550 1.3×	178 0.5×	91 0.3×	66	1.7k
Craig A. Jaffe	169 0.3×	204 0.4×	1.9k 4.5×	78 0.2×	73 0.3×	56	3.3k
Lei Xia	505 0.9×	388 0.7×	101 0.2×	91 0.3×	148 0.6×	126	1.6k
Manuel Bousoño	895 1.5×	612 1.1×	214 0.5×	80 0.2×	207 0.8×	61	1.6k
Walter Deberdt	1.1k 1.8×	334 0.6×	101 0.2×	25 0.1×	92 0.3×	62	1.8k
Lynna M. Lesko	1.5k 2.5×	287 0.5×	181 0.4×	36 0.1×	40 0.2×	37	2.7k
Annette Schröder	149 0.3×	132 0.2×	65 0.2×	943 2.7×	122 0.5×	94	1.8k

Countries citing papers authored by Michael Sweeney

Since Specialization

Citations

This map shows the geographic impact of Michael Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Sweeney more than expected).

Fields of papers citing papers by Michael Sweeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Sweeney. The network helps show where Michael Sweeney may publish in the future.

Co-authorship network of co-authors of Michael Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Sweeney. A scholar is included among the top collaborators of Michael Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Sweeney. Michael Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graves, Jennifer, Michael Sweeney, John R. Kramer, et al.. (2022). A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies. Neurology and Therapy. 11(3). 955–979. 3 indexed citations

Bar‐Or, Amit, Susan O’Brien, Michael Sweeney, Edward Fox, & Jeffrey A. Cohen. (2021). Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis. CNS Drugs. 35(9). 985–997. 35 indexed citations

Ray, Kausik K., Stephen J. Nicholls, Michael Sweeney, et al.. (2019). BET PROTEIN INHIBITION AND COGNITION: A PRE-SPECIFIED SUBSTUDY OF THE BETONMACE PHASE 3 TRIAL EVALUATING APABETALONE IN PATIENTS WITH DIABETES AND ACUTE CORONARY SYNDROME. Journal of the American College of Cardiology. 73(9). 1864–1864. 1 indexed citations

Sweeney, Michael, Matthew Sweney, M. Mateo Paz Soldán, & Stacey Clardy. (2016). Antineuronal Nuclear Autoantibody Type 1/Anti-Hu–Associated Opsoclonus Myoclonus and Epilepsia Partialis Continua: Case Report and Literature Review. Pediatric Neurology. 65. 86–89. 13 indexed citations

Freeman, Roy, Mark S. Wallace, Michael Sweeney, & M. Backonja. (2015). Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin. Pain Medicine. 16(10). 2000–2011. 11 indexed citations

Smith, Shannon M., Anthony Pereira, Daniel R. Chang, et al.. (2013). Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations. Pain. 154(12). 2769–2774. 24 indexed citations

Becker, R, et al.. (2012). PND7 Budget Impact and Cost-Effectiveness of Once-Daily Gabapentin for the Treatment of Postherpetic Neuralgia. Value in Health. 15(4). A142–A142. 1 indexed citations

Sweeney, Michael, et al.. (2012). PSY21 Health Care Costs Associated With Postherpetic Neuralgia and its Treatment With Gabapentin and Pregabalin. Value in Health. 15(4). A102–A102. 1 indexed citations

Rauck, Richard, Gordon Irving, Mark S. Wallace, Geertrui F. Vanhove, & Michael Sweeney. (2012). Once-Daily Gastroretentive Gabapentin for Postherpetic Neuralgia: Integrated Efficacy, Time to Onset of Pain Relief and Safety Analyses of Data From Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies. Journal of Pain and Symptom Management. 46(2). 219–228. 21 indexed citations

10.

Chen, Cuiping, Verne E. Cowles, Michael Sweeney, I. D. Stolyarov, & С. Н. Иллариошкин. (2012). Pharmacokinetics and Pharmacodynamics of Gastroretentive Delivery of Levodopa/Carbidopa in Patients With Parkinson Disease. Clinical Neuropharmacology. 35(2). 67–72. 21 indexed citations

11.

Hale, Sharon L., John C. Shryock, Luiz Belardinelli, Michael Sweeney, & Robert A. Kloner. (2008). Late sodium current inhibition as a new cardioprotective approach. Journal of Molecular and Cellular Cardiology. 44(6). 954–967. 115 indexed citations

12.

Roy, Amy Krain, Roma A. Vasa, Maggie Bruck, et al.. (2008). Attention Bias Toward Threat in Pediatric Anxiety Disorders. Journal of the American Academy of Child & Adolescent Psychiatry. 47(10). 1189–1196. 196 indexed citations

13.

Koren, Michael J., Michael Crager, & Michael Sweeney. (2007). Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable Angina. Journal of the American College of Cardiology. 49(10). 1027–1034. 81 indexed citations

14.

DeBusk, Robert F., et al.. (2004). Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. The American Journal of Cardiology. 93(2). 147–153. 72 indexed citations

15.

Storch, Eric A., et al.. (2002). Overt and Relational Victimization and Psychosocial Adjustment in Minority Preadolescents.. Child study journal. 32(2). 73–80. 29 indexed citations

16.

Walkup, John T., Michael J. Labellarte, Mark A. Riddle, et al.. (2002). Treatment of Pediatric Anxiety Disorders: An Open-Label Extension of the Research Units on Pediatric Psychopharmacology Anxiety Study. Journal of Child and Adolescent Psychopharmacology. 12(3). 175–188. 56 indexed citations

17.

Giuliano, François, Francesco Montorsi, Vincenzo Mirone, Dominique Rossi, & Michael Sweeney. (2000). SWITCHING FROM INTRACAVERNOUS PROSTAGLANDIN E1 INJECTIONS TO ORAL SILDENAFIL CITRATE IN PATIENTS WITH ERECTILE DYSFUNCTION: RESULTS OF A MULTICENTER EUROPEAN STUDY. The Journal of Urology. 164(3 Part 1). 708–711. 35 indexed citations

18.

Conti, C, et al.. (1999). Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. The American Journal of Cardiology. 83(5). 29–34. 152 indexed citations

19.

McGrath, Robert E., et al.. (1998). Identifying Psychological Contributions to Chronic Pain Complaints With the MMPI--2: The Role of the K Scale. Journal of Personality Assessment. 70(3). 448–459. 8 indexed citations

20.

Dick, P., Michael Sweeney, & Iain K. Crombie. (1991). Controlled Comparison of Day-patient and Out-patient Treatment for Persistent Anxiety and Depression. The British Journal of Psychiatry. 158(1). 24–27. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact